Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling - 2Unwinding the Starting points of America: An Excursion Through History
- 3Exhaustive Experiences into Prudent Senior Living in the UK
- 4Step in Style: A Survey of \Solace and Execution on the Track\ Running Shoes
- 5‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- Check out the exclusive pitch deck Valerie Health used to raise $30 million from Redpoint Ventures to automate healthcare faxes
- AstraZeneca to invest $2 billion as part of US manufacturing push
- Top Smoothie Flavor: What's Your Mix?
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Unfathomable and Entertaining Legal disputes That Surprise everyone
- 5 Food varieties to Remember for Your Eating regimen for Ideal Wellbeing
- 5 Great Youngster Care Administrations To Watch in 2024
- Geminid meteor shower 2025 peaks next week. Here's what you need to know about this year's best meteor shower
- Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
